Dancing Towards Stability: The Therapeutic Potential of Argentine Tango for Balance and Mobility in Parkinson's Disease.

Federica Giorgi, Daniela Platano, Lisa Berti, Danilo Donati, Roberto Tedeschi
Author Information
  1. Federica Giorgi: Pediatric Physical Medicine and Rehabilitation Unit, IRCCS Institute of Neurological Sciences, 40126 Bologna, Italy.
  2. Daniela Platano: Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, 40126 Bologna, Italy. ORCID
  3. Lisa Berti: Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, 40126 Bologna, Italy.
  4. Danilo Donati: Physical Therapy and Rehabilitation Unit, Policlinico di Modena, 41125 Modena, Italy.
  5. Roberto Tedeschi: Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, 40126 Bologna, Italy. ORCID

Abstract

Parkinson's Disease (PD) is a progressive neurodegenerative disorder characterized by motor impairments, including balance deficits, gait disturbances, and postural instability. Given the limitations of pharmacological treatments, alternative rehabilitative strategies such as Argentine Tango (AT) have been explored for their potential benefits in improving mobility and quality of life in individuals with PD. This systematic review evaluates the effectiveness of AT in enhancing balance, gait, and functional mobility in PD patients. A systematic literature search was conducted across PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), Scopus, PEDro, and Web of Science. Studies were included if they were randomized controlled trials (RCTs) assessing the impact of AT on motor outcomes in PD. Data extraction and risk of bias assessment were performed independently by two reviewers using the Risk of Bias 2 (RoB 2) tool. Five randomized controlled trials (RCTs) were included, with sample sizes ranging from 10 to 62 participants and intervention durations varying from 10 weeks to 24 months. AT significantly improved balance (Mini-BESTest, BBS, FRT), gait performance (6MWT, TUG), and mobility compared to usual care or conventional exercise. Some studies also reported psychological benefits, including reduced depressive symptoms and increased balance confidence. However, freezing of gait outcomes were inconclusive, and methodological limitations, such as small sample sizes and inconsistent intervention durations, were noted. Outcomes for freezing of gait (FoG) remained inconclusive due to the variability in assessment methods and inconsistent reporting across studies. AT appears to be an effective rehabilitation strategy for improving balance, gait, and functional mobility in PD. While preliminary evidence suggests additional psychological benefits, larger, high-quality trials are needed to confirm its long-term efficacy and establish standardized intervention protocols. AT may be integrated into multimodal rehabilitation programs to enhance motor and psychosocial outcomes in PD management. However, the small sample sizes of included studies and the heterogeneity in intervention durations limit the generalizability of findings. AT may serve as a structured rehabilitative approach for improving mobility and psychosocial outcomes in PD and could be integrated into community-based or clinical rehabilitation programs.

Keywords

References

  1. Neurodegener Dis Manag. 2016 Oct;6(5):431-46 [PMID: 27599588]
  2. Parkinsons Dis. 2015;2015:390512 [PMID: 26495152]
  3. J Clin Med Res. 2015 Mar;7(3):182-5 [PMID: 25584104]
  4. J Rehabil Med. 2009 May;41(6):475-81 [PMID: 19479161]
  5. Mov Disord. 2003 Jul;18(7):738-50 [PMID: 12815652]
  6. Int Rev Neurobiol. 2017;133:499-516 [PMID: 28802930]
  7. BMC Neurol. 2015 Nov 05;15:226 [PMID: 26542475]
  8. NPJ Parkinsons Dis. 2025 Jan 29;11(1):24 [PMID: 39875379]
  9. Brain Sci. 2022 Mar 27;12(4): [PMID: 35447980]
  10. J Parkinsons Dis. 2019;9(3):501-515 [PMID: 31282427]
  11. Mov Disord. 2006 Jun;21(6):761-6 [PMID: 16511869]
  12. Sensors (Basel). 2025 Jan 09;25(2): [PMID: 39860708]
  13. Mov Disord. 2009 Apr 15;24(5):655-61 [PMID: 19127595]
  14. Acta Neurol Belg. 2025 Jan 27;: [PMID: 39865165]
  15. Br J Clin Psychol. 2006 Nov;45(Pt 4):585-90 [PMID: 17076966]
  16. BMC Geriatr. 2023 Oct 24;23(1):693 [PMID: 37875856]
  17. Clin Geriatr Med. 2020 Feb;36(1):1-12 [PMID: 31733690]
  18. J Neuroeng Rehabil. 2025 Jan 30;22(1):16 [PMID: 39885573]
  19. Eur J Neurosci. 2025 Feb;61(3):e70008 [PMID: 39888085]
  20. Neurol Res Pract. 2025 Jan 30;7(1):5 [PMID: 39881414]
  21. Neurorehabil Neural Repair. 2012 Feb;26(2):132-43 [PMID: 21959675]
  22. Sci Data. 2023 Aug 25;10(1):564 [PMID: 37626087]
  23. Eur Neuropsychopharmacol. 2025 Apr;93:19-21 [PMID: 39884117]
  24. Free Radic Biol Med. 2013 Sep;62:132-144 [PMID: 23380027]
  25. ACS Omega. 2025 Jan 08;10(2):1864-1892 [PMID: 39866628]
  26. J Altern Complement Med. 2014 Oct;20(10):757-63 [PMID: 25192393]
  27. Mov Disord. 2015 Oct;30(12):1591-601 [PMID: 26474316]
  28. BMC Neurol. 2014 Dec 12;14:235 [PMID: 25496796]
  29. J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):368-76 [PMID: 18344392]
  30. Trends Neurosci. 2025 Mar;48(3):189-199 [PMID: 39884904]
  31. Mov Disord Clin Pract. 2025 Jan 29;: [PMID: 39878647]
  32. Mov Disord. 2009 Jul 30;24(10):1481-7 [PMID: 19441128]
  33. Can J Public Health. 1992 Jul-Aug;83 Suppl 2:S7-11 [PMID: 1468055]
  34. Ann Intern Med. 2018 Oct 2;169(7):467-473 [PMID: 30178033]
  35. JAMA. 2020 Feb 11;323(6):548-560 [PMID: 32044947]
  36. Lancet Neurol. 2017 Nov;16(11):877-897 [PMID: 28931491]
  37. Lancet Neurol. 2021 May;20(5):385-397 [PMID: 33894193]
  38. Complement Ther Med. 2015 Apr;23(2):175-84 [PMID: 25847555]
  39. Parkinsons Dis. 2013;2013:906274 [PMID: 23533953]
  40. J Neurol Phys Ther. 2007 Dec;31(4):173-9 [PMID: 18172414]
  41. Mov Disord. 2004 Sep;19(9):1020-8 [PMID: 15372591]
  42. Lancet. 2009 Jun 13;373(9680):2055-66 [PMID: 19524782]
  43. J Gerontol. 1990 Nov;45(6):M192-7 [PMID: 2229941]

Word Cloud

Created with Highcharts 10.0.0PDgaitATbalancemobilityoutcomesinterventionrehabilitationmotorArgentineTangobenefitsimprovingincludedtrialssamplesizesdurationsstudiesParkinson'sDiseaseincludinglimitationsrehabilitativesystematicfunctionalacrossrandomizedcontrolledRCTsassessment210psychologicalHoweverfreezinginconclusivesmallinconsistentmayintegratedprogramspsychosocialprogressiveneurodegenerativedisordercharacterizedimpairmentsdeficitsdisturbancesposturalinstabilityGivenpharmacologicaltreatmentsalternativestrategiesexploredpotentialqualitylifeindividualsreviewevaluateseffectivenessenhancingpatientsliteraturesearchconductedPubMedCochraneCentralRegisterControlledTrialsCENTRALScopusPEDroWebScienceStudiesassessingimpactDataextractionriskbiasperformedindependentlytworeviewersusingRiskBiasRoBtoolFiveranging62participantsvaryingweeks24monthssignificantlyimprovedMini-BESTestBBSFRTperformance6MWTTUGcomparedusualcareconventionalexercisealsoreportedreduceddepressivesymptomsincreasedconfidencemethodologicalnotedOutcomesFoGremainedduevariabilitymethodsreportingappearseffectivestrategypreliminaryevidencesuggestsadditionallargerhigh-qualityneededconfirmlong-termefficacyestablishstandardizedprotocolsmultimodalenhancemanagementheterogeneitylimitgeneralizabilityfindingsservestructuredapproachcommunity-basedclinicalDancingTowardsStability:TherapeuticPotentialBalanceMobilityParkinson���sdiseaseimprovementnon-pharmacologicaltherapy

Similar Articles

Cited By

No available data.